Advertisement

Neurocritical Care

, Volume 8, Issue 2, pp 293–300 | Cite as

A Critical Review of the Pathophysiology of Dysautonomia Following Traumatic Brain Injury

  • Ian J. BaguleyEmail author
  • Roxana E. Heriseanu
  • Ian D. Cameron
  • Melissa T. Nott
  • Shameran Slewa-Younan
Review Article

Abstract

The management of Dysautonomia following severe traumatic brain injury (TBI) remains problematic, primarily due to an inadequate understanding of the pathophysiology of the condition. While the original theories inferred an epileptogenic source, there is greater support for disconnection theories in the literature. Disconnection theories suggest that Dysautonomia follows the release of one or more excitatory centres from higher centre control. Conventional disconnection theories suggest excitatory centre/s located in the upper brainstem and diencephalon drive paroxysms. Another disconnection theory, the Excitatory:Inhibitory Ratio (EIR) Model, suggests the causative brainstem/diencephalic centres are inhibitory in nature, with damage releasing excitatory spinal cord processes. Review of the available data suggests that Dysautonomia follows structural and/or functional (for example raised intracerebral pressure or neurotransmitter blockade) abnormalities, with the tendency to develop Dysautonomic paroxysms being more closely associated with mesencephalic rather than diencephalic damage. Many reports suggest that paroxysmal episodes can be triggered by environmental events and minimised by various but predictable neurotransmitter effects. This article presents a critical review of the competing theories against the available observational, clinical and neurotransmitter evidence. Following this process, it is suggested that the EIR Model more readily explains pathophysiological and treatment data compared to conventional disconnection models. In particular, the EIR Model provides an explanatory model that encompasses other acute autonomic emergency syndromes, accommodates ‘triggering’ of paroxysms and provides a rationale for all known medication effects.

Keywords

Traumatic brain injury Dysautonomia ANS Overactivity Pathophysiology Review 

Notes

Acknowledgement

This work resulted, in part, from a project funded by the Motor Accidents Authority of New South Wales, Australia.

References

  1. 1.
    Baguley IJ, Nicholls JL, Felmingham KL, Crooks J, Gurka JA, Wade LD. Dysautonomia after traumatic brain injury: a forgotten syndrome? J Neurol Neurosurg Psychiatr 1999;67(1):39–43.PubMedGoogle Scholar
  2. 2.
    Baguley IJ. The excitatory:inhibitory model (EIR model): an integrative explanation of acute autonomic overactivity syndromes. Med Hypotheses 2007. doi:  10.1016/j.mehy.2007.04.037
  3. 3.
    Scott JS, Ockey RR, Holmes GE, Varghese G. Autonomic dysfunction associated with locked-in syndrome in a child. Am J Phys Med Rehabil 1997;76(3):200–3.PubMedCrossRefGoogle Scholar
  4. 4.
    Lemke DM. Riding out the storm: sympathetic storming after traumatic brain injury. J Neurosci Nurs 2004;36(1):4–9.PubMedGoogle Scholar
  5. 5.
    Kishner S, Augustin J. Post head injury autonomic complications. Last updated 2006 October 4. Available from: http://www.emedicine.com/pmr/topic108.htm.
  6. 6.
    Penfield W. Diencephalic autonomic epilepsy. Arch Neurol Psychiatry 1929;22:358–74.Google Scholar
  7. 7.
    Carmel PW. Vegetative dysfunctions of the hypothalamus. Acta Neurochirurgica 1985;75(1–4):113–21.PubMedCrossRefGoogle Scholar
  8. 8.
    Rossitch E, Bullard DE. The autonomic dysfunction syndrome: aetiology and treatment. Br J Neurosurg 1988;2:471–8.PubMedCrossRefGoogle Scholar
  9. 9.
    Pranzatelli MR, Pavlakis SG, Gould RG, De Vivo DC. Hypothalamic-midbrain dysregulation syndrome: hypertension, hyperthermia, hyperventilation, and decerebration. J Child Neurol 1991;6:115–22.PubMedGoogle Scholar
  10. 10.
    Sneed RC. Hyperpyrexia associated with sustained muscle contractions: an alternative diagnosis to central fever. Arch Phys Med Rehabil 1995;76(1):101–3.PubMedCrossRefGoogle Scholar
  11. 11.
    Boeve BF, Wijdicks EF, Benarroch EE, Schmidt KD. Paroxysmal sympathetic storms (“diencephalic seizures”) after severe diffuse axonal head injury. Mayo Clin Proc 1998;73(2):148–52.PubMedGoogle Scholar
  12. 12.
    Do D, Sheen VL, Broomfield E. Treatment of paroxysmal sympathetic storm with labetalol. J Neurol Neurosurg Psychiatr 2000;69(6):832–33.PubMedCrossRefGoogle Scholar
  13. 13.
    Thorley RR, Wertsch JJ, Klingbeil GE. Acute hypothalamic instability in traumatic brain injury: a case report. Arch Phys Med Rehabil 2001;82(2):246–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Bhigjee AI, Ames FR, Rutherford GS. Adult aqueduct stenosis and diencephalic epilepsy. A case report. J Neurol Sci 1985;71(1):77–89.PubMedCrossRefGoogle Scholar
  15. 15.
    Baguley IJ, Heriseanu RE, Gurka JA, Nordenbo A, Cameron ID. Gabapentin in the management of Dysautonomia following severe traumatic brain injury: a case series. J Neurol Neurosurg Psychiatr 2007;78(5):539–41.PubMedCrossRefGoogle Scholar
  16. 16.
    Metz SA, Halter JB, Porte D Jr, Robertson RP. Autonomic epilepsy: clonidine blockade of paroxysmal catecholamine release and flushing. Anns Int Med 1978;88(2):89–193.Google Scholar
  17. 17.
    Bernath O. Treatment of paroxysmal sympathetic storm with labetalol. J Neurol Neurosurg Psychiatr 2001;70(6):818–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Hortnagl H, Hammerle AF, Hackl JM, Brucke T, Rumpl E, Hortnagl H. The activity of the sympathetic nervous system following severe head injury. Intensive Care Med 1980;6(3):169–77.PubMedCrossRefGoogle Scholar
  19. 19.
    Klug N, Hoffman O, Zierski J, Buss K, Laun A, Agnoli AL. Decerebrate rigidity and vegetative signs in the acute midbrain syndrome with special regard to motor activity and intracranial pressure. Acta Neurochir 1984;72:219–33.CrossRefGoogle Scholar
  20. 20.
    Sandel ME, Abrams PL, Horn LJ. Hypertension after brain injury: Case report. Arch Phys Med Rehabil 1986;67:469–72.PubMedGoogle Scholar
  21. 21.
    Bullard DE. Diencephalic seizures: responsiveness to bromocriptine and morphine. Ann Neurol 1987;21(6):609–11.PubMedCrossRefGoogle Scholar
  22. 22.
    Hackl JM, Gottardis M, Wieser C, et al. Endocrine abnormalities in severe traumatic brain injury—a cue to prognosis in severe craniocerebral trauma? Intensive Care Med 1991;17(1):25–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Silver JK, Lux WE. Early onset dystonia following traumatic brain injury. Arch Phys Med Rehabil 1994;75(8):885–8.PubMedCrossRefGoogle Scholar
  24. 24.
    Baguley IJ, Heriseanu RE, Felmingham KL, Cameron ID. Dysautonomia and heart rate variability following severe traumatic brain injury. Brain Inj 2006;20(4):437–44.PubMedCrossRefGoogle Scholar
  25. 25.
    Blackman JA, Patrick PD, Buck ML, Rust RS Jr. Paroxysmal autonomic instability with dystonia after brain injury. Arch Neurol 2004;61(3):321–28.PubMedCrossRefGoogle Scholar
  26. 26.
    Meythaler JM, Stinson AM. Fever of central origin in traumatic brain injury controlled with propranolol. Arch Phys Med Rehabil 1994;75(7):816–8.PubMedGoogle Scholar
  27. 27.
    Gennarelli TA. Mechanisms and pathophysiology of cerebral concussion. J Head Trauma Rehabil 1986;1(2):23–9.Google Scholar
  28. 28.
    Isbister GK, Buckley NA. The pathophysiology of serotonin toxicity in animals and humans: implications for diagnosis and treatment. Clin Neuropharmacol 2005;28(5):205–14.PubMedCrossRefGoogle Scholar
  29. 29.
    Kipps CM, Fung VS, Grattan-Smith P, de Moore GM, Morris JG. Movement disorder emergencies.[see comment]. Mov Disord 2005;20(3):322–34.PubMedCrossRefGoogle Scholar
  30. 30.
    Mohammed I, Hussain A. Intrathecal baclofen withdrawal syndrome—a life-threatening complication of baclofen pump: a case report. BMC Clin Pharmacol 2004;4:6.PubMedCrossRefGoogle Scholar
  31. 31.
    McCarthy EJ. Malignant hyperthermia: pathophysiology, clinical presentation, and treatment. AACN Clin Issue 2004;15(2):231–7.CrossRefGoogle Scholar
  32. 32.
    Cervero F, Laird JM. Mechanisms of touch-evoked pain (allodynia): a new model. Pain 1996;68(1):13–23.PubMedCrossRefGoogle Scholar
  33. 33.
    Strich SJ. Diffuse degeneration of the cerebral white matter in severe dementia following head injury. J Neurol Neurosurg Psychiatr 1956;19:163–85.PubMedCrossRefGoogle Scholar
  34. 34.
    Cuny E, Richer E, Castel JP. Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: relief with intrathecal Baclofen therapy. Brain Inj 2001;15(10):917–25.PubMedCrossRefGoogle Scholar
  35. 35.
    Meythaler JM, Peduzzi JD, Eleftheriou E, Novack TA. Current concepts: diffuse axonal injury-associated traumatic brain injury. Arch Phys Med Rehabil 2001;82(10):1461–71.PubMedCrossRefGoogle Scholar
  36. 36.
    Fernandez-Ortega JF, Prieto-Palomino MA, Munoz-Lopez A, Lebron-Gallardo M, Cabrera-Ortiz H, Quesada-Garcia G. Prognostic influence and computed tomography findings in dysautonomic crises after traumatic brain injury. J Trauma-Injury Infect Crit Care 2006;61(5):1129–33.CrossRefGoogle Scholar
  37. 37.
    Mazey RM, Kotchen TA, Ernst CB. A syndrome resembling pheochromocytoma following a stroke. Report of a case. JAMA 1974;230(4):575–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Becker R, Benes L, Sure U, Hellwig D, Bertalanffy H. Intrathecal baclofen alleviates autonomic dysfunction in severe brain injury. J Clin Neurosci 2000;7(4):316–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Evans CH, Westfall V, Atuk NO. Astrocytoma mimicking the features of pheochromocytoma. N Engl J Med 1972;286(26):1397–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Soloman GE. Diencephalic autonomic epilepsy caused by a neoplasm. J Pediatrics 1973;83:277–80.CrossRefGoogle Scholar
  41. 41.
    Goh KYC, Conway EJ, DaRosso RC, Muszynski CA, Epstein FJ. Sympathetic storms in a child with midbrain glioma: a variant of diencephalic seizures. Pediatr Neurol 1999;21(4):742–4.PubMedCrossRefGoogle Scholar
  42. 42.
    Talman WT, Florek G, Bullard DE. A hyperthermic syndrome in two subjects with acute hydrocephalus. Arch Neurol 1988;45(9):1037–40.PubMedGoogle Scholar
  43. 43.
    Lu CS, Ryu SJ. Neuroleptic malignant-like syndrome associated with acute hydrocephalus. Mov Disord 1991;6(4):381–3.PubMedCrossRefGoogle Scholar
  44. 44.
    Baguley IJ. Nomenclature of “paroxysmal sympathetic storms”. Mayo Clin Proc 1999;74(1):105.PubMedGoogle Scholar
  45. 45.
    Diesing TS, Wijdicks EF. Arc de Cercle and Dysautonomia from anoxic injury. Mov Disord 2006;21(6):868–9.PubMedCrossRefGoogle Scholar
  46. 46.
    Howie MB, Black HA, Zvara D, McSweeney TD, Martin DJ, Coffman JA. Esmolol reduces autonomic hypersensitivity and length of seizures induced by electroconvulsive therapy. Anesth Analg 1990;71:384–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Clifton GL, Robertson CS, Kyper K, Taylor AA, Dhekne RD, Grossman RG. Cardiovascular response to severe head injury. J Neurosurg 1983;59(3):447–54.PubMedGoogle Scholar
  48. 48.
    Russo RN, O’Flaherty S. Bromocriptine for the management of autonomic dysfunction after severe traumatic brain injury. J Paediat Child Health 2000;36(3):283–5.CrossRefGoogle Scholar
  49. 49.
    Baguley IJ, Cameron ID, Green AM, Slewa-Younan S, Marosszeky JE, Gurka JA. Pharmacological management of Dysautonomia following traumatic brain injury. Brain Inj 2004;18(5):409–17.PubMedCrossRefGoogle Scholar
  50. 50.
    Lemke DM. Sympathetic storming after severe traumatic brain injury. Crit Care Nurse 2007;27(1):30–7.PubMedGoogle Scholar
  51. 51.
    Payen D, Quintin L, Plaisance P, Chiron B, Lhoste F. Head injury: clonidine decreases plasma catecholamines. Crit Care Med 1990;18(4):392–5.PubMedCrossRefGoogle Scholar
  52. 52.
    Baguley IJ, Heriseanu RE, Slewa-Younan S. Clonidine in the management of Dysautonomia following severe traumatic brain injury. Neurorehabil Neural Repair 2006;20(1):98–9.Google Scholar
  53. 53.
    Gordon WA, Zafonte R, Cicerone K, et al. Traumatic brain injury rehabilitation: state of the science. Am J Phys Med Rehabil 2006;85(4):343–82.PubMedCrossRefGoogle Scholar
  54. 54.
    Wortsman J, Burns G, Van Beek AL, Couch J. Hyperadrenergic state after trauma to the neuroaxis. J Am Med Assoc 1980;243(14):1459–60.CrossRefGoogle Scholar
  55. 55.
    Feibel JH, Baldwin CA, Joynt RJ. Catecholamine-associated refractory hypertension following acute intracranial hemorrhage: control with propranolol. Ann Neurol 1981;9(4):340–3.PubMedCrossRefGoogle Scholar
  56. 56.
    Robertson CS, Clifton GL, Taylor AA, Grossman RG. Treatment of hypertension associated with head injury. J Neurosurg 1983;59:455–60.PubMedGoogle Scholar
  57. 57.
    Chiolero RL, Breitenstein E, Thorin D, et al. Effects of propranolol on resting metabolic rate after severe head injury. Crit Care Med 1989;17(4):328–34.PubMedCrossRefGoogle Scholar
  58. 58.
    Ener RA, Meglathery SB, Van Decker WA, Gallagher RM. Serotonin syndrome and other serotonergic disorders. Pain Med 2003;4(1):63–74.PubMedCrossRefGoogle Scholar
  59. 59.
    Ivanhoe CB, Tilton AH, Francisco GE. Intrathecal baclofen therapy for spastic hypertonia. Phys Med Rehabili Clin of N Am 2001;12(4):923–38.Google Scholar
  60. 60.
    Baguley IJ, Bailey KM, Slewa-Younan S. Prolonged anti-spasticity effects of bolus intrathecal baclofen. Brain Inj 2005;19(7):545–8.PubMedCrossRefGoogle Scholar
  61. 61.
    Green LB, Nelson VS. Death after acute withdrawal of intrathecal baclofen: case report and literature review. Arch Phys Med Rehabil 1999;80(12):1600–4.PubMedCrossRefGoogle Scholar
  62. 62.
    Cheng JK, Chiou LC. Mechanisms of the antinociceptive action of gabapentin. J Pharmacol Sci 2006;100(5):471–86.PubMedCrossRefGoogle Scholar
  63. 63.
    Rose MA, Kam PC. Gabapentin: pharmacology and its use in pain management. Anaesthesia 2002;57(5):451–62.PubMedCrossRefGoogle Scholar
  64. 64.
    Sutton KG, Martin DJ, Pinnock RD, Lee K, Scott RH. Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurons. Br J Pharmacol 2002;135(1):257–65.PubMedCrossRefGoogle Scholar
  65. 65.
    Onofrj M, Thomas A. Acute akinesia in Parkinson disease. Neurology 2005;64(7):1162–9.PubMedGoogle Scholar
  66. 66.
    Figa-Talamanca L, Gualandi C, Di Meo L, Di Battista G, Neri G, Lo RF. Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause. Neurology 1985;35(2):258–61.PubMedGoogle Scholar
  67. 67.
    Meagher LJ, McKay D, Herkes GK, Needham M. Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy. J Clin Neurosci 2006;13:857–9.PubMedCrossRefGoogle Scholar
  68. 68.
    Vincent FM, Zimmerman JE, Van Haren J. Neuroleptic malignant syndrome complicating closed head injury. Neurosurgery 1986;18(2):190–3.PubMedCrossRefGoogle Scholar
  69. 69.
    Perez Vela JL, Sanchez Casado M, Sanchez Izquierdo Riera JA, Ambros Checa A, Caballero Cubedo R, Alted Lopez E. Neuroleptic malignant syndrome in a patient with head injury. Intensive Care Med 1996;22(6):593–5.PubMedCrossRefGoogle Scholar
  70. 70.
    Trasmonte J, Dayner J, Barron TF. Neuroleptic malignant syndrome in an adolescent head trauma patient. Clin Pediatr 1999;38(10):611–3.CrossRefGoogle Scholar
  71. 71.
    Rothman RB, Baumann MH. Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann N Y Acad Sci 2006;1074(8):245–60.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  • Ian J. Baguley
    • 1
    Email author
  • Roxana E. Heriseanu
    • 1
  • Ian D. Cameron
    • 2
  • Melissa T. Nott
    • 1
  • Shameran Slewa-Younan
    • 1
    • 2
  1. 1.Brain Injury Rehabilitation ServiceWestmead HospitalWentworthvilleAustralia
  2. 2.Rehabilitation Studies Unit, Faculty of MedicineUniversity of SydneySydneyAustralia

Personalised recommendations